Educational Resources

Our pathologists are recognised both nationally and internationally for their partnerships with major research affiliations. As part of our ongoing commitment to research and scientific development, SydPath provides a service based on the most recent advances in scientific pathology and laboratory technology. Our most recent publications, chapters and textbooks are listed below by pathology discipline.

Published Textbooks:


Practical Cytopathology: A Diagnostic Approach to Fine Needle Aspiration Biopsy. Andrew Field and Matthew Zarka, Philadelphia, Elsevier, 2019.


The IAC Yokohama System for Reporting Breast FNAB Cytopathology. Andrew Field, Wendy Raymond and Fernando Schmitt, Springer, 2020.


Published Book Chapters:


Field AS. Cytopathology in low Medical Infrastructure Countries: why and how to integrate to Capacitate Health Care in Clinics in Laboratory Medicine: Global Health and Pathology. Clin Lab Med 2018;38:175-182


Published Articles:


Field AS, Vielh P, Schmitt F. IAC Standardized Reporting of Breast FNA Biopsy Cytology. Acta Cytologica 2017;61:3-6


Field AS. Breast FNA biopsy cytology: current problems and the IAC Yokohama Standardized Reporting System. Cancer Cytopath 2017;125:229-230


Field AS. Cytopathology in focus: Standardized Reporting for Breast FNAB cytology. January 15 2018


Sayed S, Field A, Rajab J, et al. Task Sharing and Shifting to Provide Pathology Diagnostic Services: The Kenya Fine-Needle Aspiration Biopsy Cytology and Bone Marrow Aspiration and Trephine Biopsy Training Program. J Glob Oncol. 2018;4:1-11.


Leong T, Gayevskiy V, Steinfort DP et al. Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer. Oncogene 2018;38:1661-1675


Field AS, Raymond WA, Schmitt FS. The IAC Yokohama System for Reporting Breast FNAB Cytopathology. Acta Cytologica 2019;63:255-256


Field AS, Raymond WA, Rickard M, et al. The IAC Yokohama System for Reporting Breast FNAB Cytology. Acta Cytologica, 2019;63:257-273.


Wong S, Rickard M, Arnold L, Earls P, Bako B, Field AS. A retrospective analysis of Breast FNAB cases utilizing the IAC Yokohama System for Reporting Breast FNAB Cytology categories and the impact of Rapid On Site Evaluation. Acta Cytologica 2019;63:280-291.


Osamura RY, Matsui N, Okubo M, Chen L, Field AS. Histopathology and Cytopathology of Neuroendocrine Tumours and Carcinomas of the Breast: A Review. Acta Cytol. 2019;63(4):340-346. PMID: 31163417


Michelow P, Field AS. FNAB of spindle cell lesions of the breast: a review. Acta Cytologica 2019;63:328-329


Miller JA, An D, Shafique K, Song S, Rao RA, Viswanathan K, Eykman E, Wiles A, Ali SZ, Field AS. Mucoepidermoid carcinoma, acinic cell carcinoma and adenoid cystic carcinoma on FNAB and the Milan System; an international multi-institutional study. J Am Soc Cytopathol 2019;8:270-277


Field AS, Raymond WA, Rickard M, Schmitt F. Breast FNAB cytology: the potential impact of the IAC Yokohama System for reporting breast FNAB Cytopathology and the use of ROSE. J Am Soc Cytopathol. 2020;9:103-111


Zeppa P, Cozzolino I, Caraway N, et al. Announcement: the International System for Reporting Lymph Node Cytopathology. Acta Cytologica 2020;64:299-305.


Al-Abbadi MA, Barroca H, Bode-Lesniewska B, et al. A proposal for the performance, classification and reporting of lymph node FNA Cytopathology: the Sydney System. Acta Cytologica 2020:64:306-322. DOI.10.1159/000506497


Johnson DN, Onenerk M, Krane JF, et al. Cytologic grading of primary malignant salivary gland tumors: a blinded review by an international panel. Cancer Cytopathol. 2020;128:392-402. PMID: 32267606


Arnold A, Borecky N, Geddies DA, Field AS, Lydiard L. Melioidosis breast abscess diagnosed by screening mammography. Breast 2020;26:2070-2071. PMID: 32978864


Allison DB, Smith AP, An D, et al. Assessing the diagnostic accuracy of pleomorphic adenoma and Warthin Tumor by employing the Milan System for reporting salivary gland cytopathology. An international multi-institutional study. Cancer Cytopathol. 2021;129:43-52. PMID: 32767837


Field AS, Kurtycz DFI, Raymond WA, Schmitt F. The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: Analysis and discussion of the response to a web-based survey. Cancer Cytopathol. 2021;129:450-459. PMID: 33369266


Field AS, Raymond WA, Schmitt F. The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: Recent research findings and the future. Cancer Cytopathol. 2021;129:847-851


Al-Abbadi M, Barroca H, Bode-Lesniewska B, Calaminici M, Chhieng DC, Cozzolino I, Ehinger M, Field AS et al. Letter to the Editor: Fine needle aspiration cytology and core needle biopsy in the diagnosis of lymphadenopathies: words of endorsement. Eur J Haematology. 2021;107:295-296


Lin V, Chung IY, Toumi E, McKay D, McKenzie J, McKelvie P, Zabih F, Hoffmeister A, Wright D, Ntzaferi A, Wu IJ, Hesson L, Fung A, Lim LA, Wong S, Field A, Earls P, Giblin M, Conway RM, Cherepanoff S. Biopsy for molecular risk stratification in uveal melanoma: Yields and molecular characteristics in 119 patients. Clin Exp Ophthalmol. 2021 October 29 Online ahead of print. PMID: 34714583


Haifer C, Paramsothy S, Kaakoush NO, Saikal A, Ghaly S, Yang T, Luu LDW, Borody TJ, Leong RW. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):141-151. doi: 10.1016/S2468-1253(21)00400-3. Epub 2021 Dec 2. PMID: 34863330..


Aghajani M, Yang T, Schmitz U, James A, McCafferty C, de Souza P, Niles N, Roberts T. Epithelial-to-Mesenchymal Transition and its Association with PD-L1 and CD8 in Thyroid Cancer. Endocr Connect. 2020 Oct;9(10):1028-1041. doi: 10.1530/EC-20-0268. PMID: 33112841; PMCID: PMC7707834.


Meredith T, Dharan N, Killen L, Anandabaskaran S, Kim A, Yang T, Marriott D, Hayward C, Macdonald P. Colonic malakoplakia in a dual stem-cell and cardiac transplant recipient: a case report and literature review. Transpl Infect Dis. 2020 Oct 9:e13488. doi: 10.1111/tid.13488. Epub ahead of print. PMID: 33034139.


Rajendra S, Sharma P, Gautam SD, Saxena M, Kapur A, Sharma P, Merrett N, Yang T, Santos LD, Pavey D, Sharaiha O, McKay O, Dixson H, Xuan W. Association of Biomarkers for Human Papillomavirus With Survival Among Adults With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma. JAMA Netw Open. 2020 Feb 5;3(2):e1921189.


Aghajani M, Roberts T, Yang T, McCafferty C, Caixeiro N, DeSouza P, Niles N. Elevated levels of soluble PD-L1 are associated with reduced recurrence in papillary thyroid cancer. Endocr Connect. 2019 Jun 1


Dai P, Furlong T, Gracie G, Huang ML, Yang T, Wu KHC, Danta M, Wong M, Williams A, March L, Hetherington M, Heyworth-Smith D, Phan TG. Autoinflammation Masquerading as Autoimmunity in an Adult with Heterozygous p.E250K PSTPIP1 Mutation. J Clin Immunol. 2019 May 22. doi: 10.1007/s10875-019-00646-z. [Epub ahead of print] PubMed PMID: 31119601.


Rajendra S, Xuan W, Merrett N, Sharma P, Sharma P, Pavey D, Yang T, Santos LD, Sharaiha O, Pande G, Cosman P, Wu X, Wang B Survival Rates for Patients with Barrett High-grade Dysplasia and Esophageal Adenocarcinoma with or Without Human Papillomavirus Infection. JAMA Network Open.2018;1(4):e181054. doi:10.1001/jamanetworkopen.2018.1054


Aghajani M, Graham S, McCafferty C, Shaheed C, Roberts T, DeSousa P, Yang T, Niles N. The clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with non-medullary thyroid cancer: a systematic review and meta-analysis.  Thyroid. 2018 Mar;28(3):349-361. doi: 10.1089/thy.2017.0441.


Aghajani, M., Yang, T., McCafferty, C., Graham, S., Wu, X. and Niles, N. Predictive relevance of programmed cell death protein 1 and tumor-infiltrating lymphocyte expression in papillary thyroid cancer, Surgery, 2018 vol 163 (1): 130 – 136.


Rajendra S, Yang T, Xuan W, Sharma P, Pavey D, Soon Lee C, Le S, Collins J, Wang B. Active human papillomavirus involvement in Barrett’s dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway. Int J Cancer. 2017 Nov 15;141(10):2037-2049


Song WZ, Mazzieri R, Yang T, Gobe GC. Translational significance for tumor metastasis of tumor-associated macrophages and epithelial–mesenchymal transition. Front Immunol. 2017 Sep 13;8:1106.


Jideh B, Yang T, Turner I. Rectal Bleeding Due to Leiomyosarcoma. Clin Gastroenterol Hepatol. 2017 Jan;15(1):e1-e2.


Ho J, Earls P, Harvey RJ. Systemic biomarkers of eosinophilic chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2020 Feb;20(1):23-29


Lenders NF, Wilkinson AC, Wong SJ, Shein TT, Harvey RJ, Inder WJ, Earls PE, McCormack AI. Transcription factor immunohistochemistry in the diagnosis of pituitary tumours. Eur J Endocrinol. 2021 May 10;184(6):891-901


Asa SL, et al, Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution. Pituitary. 2020 Jun;23(3):322-325.


Hamizan AW, Azer M, Alvarado R, Earls P, Barham HP, Tattersall J, Rimmer J, Kalish L, Sewell WA, Harvey R. The Distinguishing Clinical Features of Nonallergic Rhinitis Patients. Am J Rhinol Allergy. 2019 Sep;33(5):524-530. doi: 10.1177/1945892419850750. Epub 2019 May 20.


Ho J, Alvarado R, Rimmer J, Sewell WA, Walter S, Earls P, Campbell RG, Sacks R, Kalish LH, Harvey RJ. Comparison of Sinonasal Histopathological Changes in Biological Treatment of Eosinophilic Chronic Rhinosinusitis. Am J Rhinol Allergy. 2022 Jan;36(1):72-80.


Lin V, Chung IY, Toumi E, McKay D, McKenzie J, McKelvie P, Zabih F, Hoffmeister A, Wright D, Ntzaferi A, Wu IJ, Hesson L, Fung A, Lim LA, Wong S, Field A, Earls P, Giblin M, Conway RM, Cherepanoff S. Biopsy for molecular risk stratification in uveal melanoma: Yields and molecular characteristics in 119 patients. Clin Exp Ophthalmol. 2022 Jan;50(1):50-61.


Rom D, Bassiouni A, Eykman E, Liu Z, Paramasivan S, Alvarado R, Earls P, Psaltis AJ, Harvey RJ. The Association Between Disease Severity and Microbiome in Chronic Rhinosinusitis. Laryngoscope. 2019 Jun;129(6):1265-1273.


Jabbour J, Agostinho N, Bains HK, Earls P, Killen L, Perera R, Sirigiri R, Ridha H. Lump at the back of my tongue. The lingual thyroid-A case report and narrative review of literature. Clin Case Rep. 2021 May 6;9(6):e04160.


Ross J, Greaves J, Saville M, Earls P, Pagliuso J. Performance measures for Australian laboratories reporting cervical cytology 2009-2017: the impact of the national HPV vaccination program. Pathology. 2020 Aug;52(5):522-528.


Whittaker B, Frydenberg E, Earls P, Wang D, Steel T. Rare radiculopathy from an osteochondral loose body: a case report and literature review. AME Case Rep. 2019 Oct 11;3:38.


Chakravorty A, Frydenberg E, Shein TT, Ly J, Earls P, Steel T. Multifocal intradural extramedullary anaplastic ependymoma of the spine. J Spine Surg. 2017 Dec;3(4):727-731.


Lee J, Emmett L, Tang R, Ho B, Earls P, Matthews T, Gallagher R. Prospective evaluation of the impact of human papilloma virus status and small node size on the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary head and neck squamous cell carcinoma. ANZ J Surg. 2020 Jul;90(7-8):1396-1401.


Wong S, Rickard M, Earls P, Arnold L, Bako B, Field AS. The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: A Single Institutional Retrospective Study of the Application of the System Categories and the Impact of Rapid Onsite Evaluation. Acta Cytol. 2019;63(4):280-291


McCabe MJ, Pinese M, Chan CL, Sheriff N, Thompson TJ, Grady J, Wong M, Gauthier MA, Puttick C, Gayevskiy V, Hajdu E, Wong SQ, Barrett W, Earls P, Lukeis R, Cheng YY, Lin RCY, Thomas DM, Watkins DN, Dinger ME, McCormack AI, Cowley MJ. Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases. Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2).


Christensen JM, Cheng J, Earls P, Gunton J, Sewell W, Sacks R, Harvey RJ. Vitamin D pathway regulatory genes encoding 1α-hydroxylase and 24-hydroxylase are dysregulated in sinonasal tissue during chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017 Feb;7(2):169-176


De Sousa SMC, McCabe MJ, Wu K, Roscioli T, Gayevskiy V, Brook K, Rawlings L, Scott HS, Thompson TJ, Earls P, Gill AJ, Cowley MJ, Dinger ME, McCormack AI. Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours. Eur J Endocrinol. 2017 May;176(5):635-644.


Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, Thennavan A, Wang C, Torpy JR, Bartonicek N, Wang T, Larsson L, Kaczorowski D, Weisenfeld NI, Uytingco CR, Chew JG, Bent ZW, Chan CL, Gnanasambandapillai V, Dutertre CA, Gluch L, Hui MN, Beith J, Parker A, Robbins E, Segara D, Cooper C, Mak C, Chan B, Warrier S, Ginhoux F, Millar E, Powell JE, Williams SR, Liu XS, O’Toole S, Lim E, Lundeberg J, Perou CM, Swarbrick A (2021). A single-cell and spatially resolved atlas of human breast cancers. Nature Genetics, 53(9), 1334-1347.


Freelander, A., Brown, L. J., Parker, A., Segara, D., Portman, N., Lau, B., & Lim, E. (2021). Molecular biomarkers for contemporary therapies in hormone receptor‐positive breast cancer. Genes, 12(2), 1-24.


Pembroke, J. S., Joseph, J. E., Smith, S. A. B. C., Parker, A. J. C., Jiang, W., & Sewell, W. A. (2021). Comparison of flow cytometry with other modalities in the diagnosis of myelodysplastic syndrome. International Journal of Laboratory Hematology.


Chia, K. M., Freelander, A., Kumar, S., Parker, A., Segara, D., Portman, N., & Lim, E. (2020). Estrogen receptor positive breast cancer patient derived xenograft models in translational research. Current Opinion in Endocrine and Metabolic Research, 15, 31-36.


Sideris A, Rao A, Maher N, Parker A, Crawford J, Smee R, Jacobson I, Gallagher R (2021). Acinic cell carcinoma of the salivary gland in the adult and paediatric population: a survival analysis. ANZ Journal of Surgery, 91(6), 1233-1239


Wu SZ, Roden DL, Wang C, Holliday H, Harvey K, Cazet AS, Murphy KJ, Pereira B, Al-Eryani G, Bartonicek N, Hou R, Torpy JR, Junankar S, Chan CL, Lam CE, Hui MN, Gluch L, Beith J, Parker A, Robbins E, Segara D, Mak C, Cooper C, Warrier S, Forrest A, Powell J, O’Toole S, Cox TR, Timpson P, Lim E, Liu XS, Swarbrick A (2020). Stromal cell diversity associated with immune evasion in human triple-negative breast cancer. EMBO Journal, 39(19).


Portman N, Milioli HH, Alexandrou S, Coulson R, Yong A, Fernandez KJ, Chia KM, Halilovic E, Segara D, Parker A, Haupt S, Haupt Y, Tilley WD, Swarbrick A, Caldon CE, Lim E (2020). MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer. Breast Cancer Research, 22(1).


Yap JY, Gloss B, Batten M, Hsu P, Berglund L, Cai F, Dai P, Parker A, Qiu M, Miley W, Roshan R, Marshall V, Whitby D, Wegman E, Garsia R, Wu KHC, Kirk E, Polizzotto M, Deenick EK, Tangye SG, Ma CS, CIRCA, Phan TG (2020). Everolimus-Induced Remission of Classic Kaposiís Sarcoma Secondary to Cryptic Splicing Mediated CTLA4 Haploinsufficiency. Journal of Clinical Immunology, 40(5), 774-779.


Portman N, Milioli HH, Alexandrou S, Coulson R, Yong A, Fernandez KJ, Chia KM, Segara D, Parker A, Haupt S, Haupt Y, Tilley WD, Swarbrick A, Caldon CE, Lim E. (2020) MDM2 Inhibition in Combination with Endocrine Therapy and CDK4/6 Inhibition for the Treatment of ER-Positive Breast Cancer. Breast Cancer Research 22(1).


Middleton, K., Wong, S., & Parker, A. (2020). 35. Follicular dendritic cell sarcoma of the nasopharynx. Pathology, 52, S145.


Chen J, Easwaralingam N, Warrier S, Ong A, Carson EK, Mak C, Snook K, Middleton K, Parker A, Palmieri C, Spillane A, Mann GB, Lim E, Segara D (2020). Window of opportunity treatment in breast cancer. ANZ Journal of Surgery, 90(1-2), 34-40.


Chia KM, Milioli H, Portman N, Laven-Law G, Coulson R, Yong A, Segara D, Parker A, Caldon CE, Deng N, Swarbrick A, Tilley WD, Hickey TE, Lim E (2019). Non-canonical AR activity facilitates endocrine resistance in breast cancer. Endocrine-Related Cancer, 26(2), 251-264.


McCarthy R-L, McNamee N, Copelin B, Mills G, Wong S, Qiu MR, Earls P, Milliken S, Hamad N, Fay K, Lukeis R, Parker A, Moore J (2019). A case series of langerhans cell histiocytosis with braf testing. Pathology, 51, S92.


Moran I, Nguyen A, Khoo WH, Butt D, Bourne K, Young C, Hermes JR, Biro M, Gracie G, Ma CS, Munier CML, Luciani F, Zaunders J, Parker A, Kelleher AD, Tangye SG, Croucher PI, Brink R, Read MN, Phan TG. (2018). Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes. Nature Communications, 9(1).


Lim, E., Portman, N., Wahlroos, S., Parker, A., & Segara, D. (2017). Endocrine therapy for breast cancer: A Renaissance. The Endocrinologist, (Winter), 13-14.


Tran, D. N., Smith, S. A. B. C., Brown, D. A., Parker, A. J. C., Joseph, J. E., Armstrong, N., & Sewell, W. A. (2017). Polychromatic flow cytometry is more sensitive than microscopy in detecting small monoclonal plasma cell populations. Cytometry Part B – Clinical Cytometry, 92(2), 136-144.


Liang, S., Huang M., Wang B., Qiu, M. Pericardial Rosai Dorfman disease: the role of next generation sequencing [conference presentation]. Pathology Update 2021, ICC, Darling Harbour, Sydney


Dai, P., Furlong, T., Gracie, G., Huang M., Yang, T., Wu, KHC., Danta, M., Wong, M., Williams, A., March, L., Hetherington, M., Heyworth-Smith, D., and Phan, TG. (2019) Autoinflammation Masquerading as autoimmunity in an adult with heterozygous p.E250K PSTPIP1 mutation. Journal of Clinical Immunology 39: 519-522


Huang M., Krigstein, M., Joseph, J., and Field, A. Classic histological features of Gaucher disease – a case report [conference presentation]. Australasian division of the International Academy of Pathology Conference 2019, ICC, Darling Harbour, Sydney


Huang, M., Chou, A., Riley, D., Kim, Y., Lukeis, R., and Qiu, M. Case report of unusual ALK gene rearrangement and review of 354 cases of ALK rearrangement in non-small cell lung carcinomas [conference presentation]. Australasian division of the International Academy of Pathology Conference 2018, ICC, Darling Harbour, Sydney


Huang, M., and Shingde, M. Classic Whipples disease presenting with shortness of breath – a case report [conference presentation]. Australasian division of the International Academy of Pathology Conference 2017, ICC, Darling Harbour, Sydney


A signal-seeking phase IIa trial of palbociclib in advanced cancers with cell cycle pathway alterations – A study within the Molecular Screening and Therapeutics (MoST) program. Submitted to JCO Precision Oncology.


Chris Anthony. et al, Cardiovascular Magnetic Resonance for Rejection Surveillance after Cardiac Transplantation. Submitted to Circulation.


S.Wiltshire, J. Nadel, T. Meredith, C. Kessler Iglesias, M. Qiu, P. Macdonald, A. Jabbour. Twice bitten, thrice shy: A case of recurrent isolated cardiac sarcoidosis in the transplanted heart. J Am Coll Cardiol Case Rep. 2021 Mar, 3 (3) 427–432.


Arcadi Cipponi1, David L. Goode, Justin Bedo, Anthony T. Papenfuss, Mark J. McCabe, Pavel Lobachevsky12, Simon R. Junanakar, Mark Cowley, Ana C. Vargas, Min R. Qiu, Daniele G. Generali, Uyen Nguyen, Niall M. Corcoran, Georgina V. Long, Marina Pajic. Jean-Yves Blay & David M. Thomas. MTOR signaling orchestrates stress-induced mutagenesis facilitating adaptive evolution in human cancers. Science.  368 (6495), 1127-1131. Jun 2020


Jain, P. and Robson, D. and Shehab, S. and Muthiah, K. and Jansz, P. and Qiu, M.R. and Barrett, W. and Sivasubramaniam, V. and Kumaradevan, N. and Macdonald, P.S. and Hayward, C.S. (2020) In vivo tissue reaction within the outflow conduit in patients supported by HeartWare HVAD. Cardiovascular Pathology, 44. p. 107156. ISSN 10548807


Ana Vargas; Caroline Kurek; Fiona Bonar;Fiona Maclean; Min Qiu; Richard Boyle; Ross Brookwell; Anthony Gill; A “Double-Hit” Translocation Sarcoma—First Report of the Co-occurrence of EWSR1-FLI1 and MTMR2-NTRK2 Fusion in a Small Round Blue Cell Sarcoma. AJSP: Reviews & Reports. 25(2):97–100, April 2020


Gao L, Hicks M, Villanueva JE, Doyle A, Chew HC,Qiu MR, Jabbour A, Dhital KK, Macdonald PS. Cyclosporine A as a cardioprotective agent during donor heart retrieval, storage or transportation – benefits and limitations. Transplantation. 2019 Feb 19


Villanueva JE, Gao L, Chew HC, Hicks M, Doyle 1, Qui MR, Dhital KK, Macdonald PS, Jabbour A. Functional recovery after Dantrolene-supplementation of cold stored hearts using an ex vivo isolated working rat heart model. PLoS One. 2018 Oct 12;13(10).


Non author contributor: Min Ru Qiu (quality assessment of archival material) Subotheni Thavaneswaran, Lucille Sebastian, Mandy Ballinger, Megan Best, DominiqueHess,Chee K Lee, Katrin M Sjoquist, Wendy E Hague, Phyllis N Butow, R John Simes and David Thomas . Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancersMed J Aust 2018; 209 (8): 354-355.


Fátima Valdés-Mora, Cathryn M Gould, Wenjia Qu, Fabian A Buske, Aaron L Statham, Shalima S Nair, Nicola J Armstrong, James G Kench, Kenneth M L Lee, Lisa G Horvath, Min RU Qiu, Yolanda Colino-Sanguino, David Gallego-Ortega, Jenny Song, Clare Stirzaker and Susan J Clark. Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer. Nature Commucations 2017 8;1346

Published Articles:


Hodgkins C, Cordwell S, Kocic D. Teaching a New Dog Old Tricks: Ultra-fast liquid-chromatogra… : Therapeutic Drug Monitoring ( 2022.


Reuter, S et al. Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. 2022.


Menz B et al. Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology. British Journal of Clinical Pharmacology. 2020


Cattaneo D, Corona A, Giuseppe De Rosa F, Gervasoni C, Kocic D & Marriott DJ. The management of anti-infective agents in intensive care units: the potential role of a ‘fast’ pharmacology. Expert Review of Clinical Pharmacology, 2019.


Wong, C.; Kumar, S. S.; Graham, G. G.; Begg, E. J.; Chin, P. K.; Brett, J.; Ray, J. E.; Marriott, D. J.; Williams, K. W.; Day, R. O. Comparing dose prediction software used to manage gentamicin dosing. Intern Med J. 2013;43(5):519-25. Epub 2013/01/03.


Williams, C. M.; Maher, C. G.; Latimer, J.; McLachlan, A. J.; Hancock, M. J.; Day, R. O.; Billot, L.; Lin, C. W. PACE – the first placebo controlled trial of paracetamol for acute low back pain: statistical analysis plan. Trials. 2013;14:248.


Westbrook, J. I.; Baysari, M. T.; Li, L.; Burke, R.; Richardson, K.; Day, R. O. The safety of electronic prescribing: Rates, manifestations and mechanisms of system-related errors associated with two commercial systems in hospitals. J Am Med Inform Assoc. 2013;0:1-9.


Teo, C.; Baysari, M. T.; Day, R. Understanding compliance to an antibiotic prescribing policy: Perspectives of policymakers and prescribers. J Pharm Pract Res. 2013;43(1):32-6.


Ramasamy, S. N.; Korb-Wells, C. S.; Kannangara, D. R. W.; Smith, M. W. H.; Wang, N.; Roberts, D. M.; Graham, G. G.; Williams, K. M.; Day, R. O. Allopurinol hypersensitivity: A systematic review of all published cases, 1950 – 2012. Drug Saf. 2013;(Online first; 2013/07/20).


Perera, V.; Dolton, M. J.; McLachlan, A. J.; Carr, V. J.; Day, R. O. Pharmacometrics: An underutilised resource in Australian clinical research. The Medical Journal of Australia. 2013;(Accepted 15/8/13).


Mathieson, S.; Maher, C. G.; McLachlan, A. J.; Latimer, J.; Koes, B. W.; Hancock, M. J.; Harris, I.; Day, R. O.; Pik, J.; Jan, S.; Billot, L.; Lin, C. W. PRECISE – pregabalin in addition to usual care for sciatica: study protocol for a randomised controlled trial. Trials. 2013;14(1):213. Epub 2013/07/13.


Lipworth, W. L.; Kerridge, I. H.; Day, R. O. Formulating an Ethics Agenda for Drug Development, Regulation, and Utilization. Therapeutic Innovation & Regulatory Science. 2013;47(1):46-9.


Lewis, J. R. R.; Lipworth, W. L.; Kerridge, I. H.; Day, R. O. The economic evaluation of personalised oncology medicines: Ethical challenges. The Medical Journal of Australia. 2013;199(7):471-3.


Lee, P.; Day, R. O.; Greenfield, J.; Ho, K. Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men. International Journal of Obesity. 2013;37(4):593-7. Epub 2012/05/29.


Lee, M. H.; Stocker, S. L.; Williams, K. M.; Day, R. O. HLA-B*5801 should be used to screen for risk of Stevens-Johnson Syndrome (SJS) in family members of Han-Chinese patients commencing allopurinol therapy. J Rheumatol. 2013;40(1):96-7.


Kannangara, D. R. W.; Graham, G. G.; Williams, K. M.; Day, R. O. Hypouricemic Effects of Prednisone and Allopurinol: An Uneven Playing Field? Can J Cardiol. 2013. Epub 2013/07/13.


Jaensch, S. L.; Baysari, M. T.; Day, R. O.; Westbrook, J. I. Junior doctors’ prescribing work after-hours and the impact of computerized decision support. Int J Med Inform. 2013;(Accepted 30 June 2013).


Graham, G. G.; Kannangara, D. R. W.; Stocker, S. L.; Portek, I.; Pile, K. D.; Indraratna, P. L.; Datta, I.; Williams, K. M.; Day, R. O. Understanding the dose-response relationship of allopurinol: predicting the optimal dosage. Brit J Clin Pharmacol. 2013;(Accepted 18th March 2013).


Graham, G. G.; Day, R. O. Salicylates. In: Parnham MJ, editor. Encyclopedia of Inflammatory Diseases2013.


Graham, G. G.; Davies, M. J.; Day, R. O.; Mohamudally, A.; Scott, K. F. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacol. 2013:1-32. Epub 2013/05/30.
Ghinea, N.; Lipworth, W.; Kerridge, I.; Day, R. Overcoming entrenched disagreements. The case of misoprostol for post-partum haemorrhage. Developing World Bioethics. 2013;(Accepted 16th June 2013).


Gallego, B.; Runciman, W. B.; Perez-Concha, O.; Liaw, S.-T.; Day, R. O.; Dunn, A. G.; Coeira, E. The management of severe hypertension in Australian general practice. BMC Health Services Research. 2013.


Duong, J. K.; Kumar, S. S.; Kirkpatrick, C. M.; Greenup, L. C.; Arora, M.; Lee, T. C.; Timmins, P.; Graham, G. G.; Furlong, T. J.; Greenfield, J. R.; Williams, K. M.; Day, R. O. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes: Simulation of doses according to renal function. Clin Pharmacokinet. 2013. Epub 2013 Mar 9.


Duong, J. K.; Furlong, T. J.; Roberts, D. M.; Graham, G. G.; Greenfield, J. R.; Williams, K. M.; Day, R. O. The role of metformin in metformin-associated lactic acidosis (MALA): Case series and formulation of a model of pathogenesis. Drug Saf. 2013. Epub 2013/04/03.


Day, R. O.; Williams, K. M.; Graham, G. G. Urate-lowering therapy: uricosurics. Gout: Future Medicine Ltd; 2013. p. 174-88.


Day, R. O.; Lee, M. H.; Graham, G. G.; Williams, K. M. Benzbromarone: Availability for general prescribing in New Zealand. The New Zealand Medical Journal. 2013;(Accepted 3/9/13).


Day, R. O.; Graham, G. G.; Williams, K. M. Propionic acid derivative drugs (Profens). In: Parnham MJ, editor. Encyclopedia of Inflammatory Diseases2013.


Day, R. O.; Graham, G. G. Non-steroidal anti-inflammatory drugs. In: Parnham MJ, editor. Encyclopedia of Inflammatory Diseases2013.


Day, R. O.; Graham, G. G. Non-steroidal anti-inflammatory drugs (NSAIDs). BMJ (Clinical research ed). 2013;346:f3195.


Carmichael, S. J.; Day, R. O.; Tett, S. E. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus. Intern Med J. 2013;43(5):547-53.


Brett, J.; Lam, V.; Baysari, M. T.; Milder, T.; Killen, L.; Chau, A. M. T.; McMullan, B.; Harkness, J.; Marriot, D.; Day, R. O. Use of pneumonia severity scores and antibiotic prescribing in the management of community-acquired pneumonia at an Australian tertiary teaching hospital. J Pharm Pract Res. 2013;43(2):97-100.


Brett, J.; Chong, O.; Graham, G. G.; Ray, J. E.; Marriott, D.; Williams, K. M.; Day, R. O. Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patients. Ther Drug Monit. 2013;35(1):133-6. Epub 2012/11/29.


Baysari, M. T.; Westbrook, J. I.; Egan, E.; Day, R. O. Identification of strategies to reduce computerized alerts in an electronic prescribing system using a Delphi approach. In: Lehmann CU, Ammenwerth E, Nøhr C, editors. Studies in health technology and informatics: IMIA and IOS Press; 2013. p. 8-12.


Arabadzhiyska, P.; Baysari, M. T.; Walter, S.; Day, R. O.; Westbrook, J. Shedding light on junior doctors’ work practices after hours. Intern Med J. 2013;(Accepted 18th June 2013).


Westbrook, J. I.; Reckmann, M.; Li, L.; Runciman, W. B.; Burke, R.; Lo, C.; Baysari, M. T.; Braithwaite, J.; Day, R. O. Effects of two commercial electronic prescribing systems on prescribing error rates in hospital in-patients: A before and after study. PLoS medicine. 2012;9(1):e1001164. Epub 2012/02/04.


Stocker, S. L.; McLachlan, A. J.; Savic, R. M.; Kirkpatrick, C. M.; Graham, G. G.; Williams, K. M.; Day, R. O. The pharmacokinetics of oxypurinol in people with gout. Br J Clin Pharmacol. 2012;74(3):477-89.


Runciman, W. B.; Hunt, T. D.; Hannaford, N. A.; Hibbert, P. D.; Westbrook, J. I.; Coiera, E. W.; Day, R. O.; Hindmarsh, D. M.; McGlynn, E. A.; Braithwaite, J. CareTrack: Assessing the appropriateness of health care delivery in Australia. Med J Aust. 2012;197(2):100-5. Epub 2012/07/17.


Runciman, W. B.; Coiera, E. W.; Day, R. O.; Hannaford, N. A.; Hibbert, P. D.; Hunt, T. D.; Westbrook, J. I.; Braithwaite, J. Towards the delivery of appropriate health care in Australia. Med J Aust. 2012;197(2):78-81. Epub 2012/07/17.


Lipworth, W. L.; Kerridge, I. H.; Day, R. O. Wrong questions, wrong answers? Are we getting the drugs we need? Clin Pharmacol Ther. 2012;91(3):367-9. Epub 2012/02/22.


Lipworth, W. L.; Kerridge, I.; Day, R. O. Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda. Med J Aust. 2012;196(6):374-5. Epub 2012/04/05.


Lipworth, W.; Kerridge, I.; Little, M.; Day, R. Evidence and desperation in off-label prescribing: Recombinant factor VIIa. BMJ (Clinical research ed). 2012;344:d7926.


Lipworth, W.; Kerridge, I.; Day, R. O.; Ho, K. Drug policy at the margins: The case of growth hormone replacement for adults with severe growth hormone deficiency. Med J Aust. 2012;197(4):204-5.


Lee, M. H.; Stocker, S. L.; Anderson, J.; Phillips, E. J.; Nolan, D.; Williams, K. M.; Graham, G. G.; Sullivan, J. R.; Day, R. O. Initiating allopurinol therapy: Do we need to know the patient’s human leucocyte antigen status? Intern Med J. 2012;42(4):411-6. Epub 2011/07/28.


Kannangara, D. R.; Roberts, D. M.; Furlong, T. J.; Graham, G. G.; Williams, K. M.; Day, R. O. Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease. Br J Clin Pharmacol. 2012;73(5):828-9. Epub 2011/11/22.


Kannangara, D. R.; Ramasamy, S. N.; Indraratna, P. L.; Stocker, S. L.; Graham, G. G.; Jones, G.; Portek, I.; Williams, K. M.; Day, R. O. Fractional clearance of urate: Validation of measurement in spot urine samples in healthy subjects and gouty patients. Arthritis Res Ther. 2012;14(4):R189. Epub 2012/08/21.


Hunt, T. D.; Ramanathan, S. A.; Hannaford, N. A.; Hibbert, P. D.; Braithwaite, J.; Coiera, E.; Day, R. O.; Westbrook, J. I.; Runciman, W. B. CareTrack Australia: Assessing the appropriateness of adult healthcare: Protocol for a retrospective medical record review. BMJ open. 2012;2:e000665. Epub 2012/01/21.


Ghinea, N.; Lipworth, W.; Kerridge, I.; Day, R. No evidence or no alternative? Taking responsibility for off-label prescribing. Intern Med J. 2012;42(3):247-51. Epub 2012/03/22.


Fransen, M.; Agaliotis, M.; Nairn, L.; Votrubec, M.; Bridgett, L.; Su, S.; Jan, S.; March, L.; Edmonds, J.; Bridges-Webb, C.; Norton, R.; Woodward, M.; Day, R. Glucosamine and Chondroitin for Knee Osteoarthritis: A Double-Blind Randomised Placebo-Controlled Clinical Trial Evaluating Single and Combination Regimens. ACR/ARHP Annual Meeting2012.


Duong, J. K.; Roberts, D. M.; Furlong, T. J.; Kumar, S. S.; Greenfield, J. R.; Kirkpatrick, C. M.; Graham, G. G.; Williams, K. M.; Day, R. O. Metformin therapy in patients with chronic kidney disease. Diabetes, obesity & metabolism. 2012;14(10):963-5. Epub 2012/05/09.


Dunn, A. G.; Day, R. O.; Mandl, K. D.; Coiera, E. Learning from hackers: Open-source clinical trials. Science translational medicine. 2012;4(132):132cm5. Epub 2012/05/04.


Dunn, A. G.; Bourgeois, F. T.; Murthy, S.; Mandl, K. D.; Day, R. O.; Coiera, E. The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics. Clin Pharmacol Ther. 2012;91(4):685-91. Epub 2012/03/02.


Dunn, A.; Braithwaite, J.; Gallego, B.; Day, R.; Runciman, W.; Coiera, E. Nation-scale adoption of new medicines by doctors: An application of the Bass diffusion model. BMC Health Services Research. 2012;12(1):248.


Day, R. O.; Kannangara, D. R. W.; Hayes, J. M.; Furlong, T. J. Successful use of allopurinol in a patient on dialysis. BMJ Case Reports. 2012:10.1136/bcr.02.2012.5814,


Baysari, M. T.; Westbrook, J. I.; Day, R. O. Understanding doctors’ perceptions of their prescribing competency and the value they ascribe to an electronic prescribing system. Studies in health technology and informatics. 2012;178:1-6. Epub 2012/07/17.


Baysari, M. T.; Tang, T.; Brett, J.; Day, R. O. Implementation of revised aminoglycoside guidelines: Australian hospitals ‘left in the lurch’. Journal of Pharmacy Practice and Research. 2012;42(3):178-9.


Baysari, M. T.; Reckmann, M. H.; Li, L.; Day, R. O.; Westbrook, J. I. Failure to utilize functions of an electronic prescribing system and the subsequent generation of ‘technically preventable’ computerized alerts. J Am Med Inform Assoc. 2012;19:1003-10. Epub 2012/06/28.


Baysari, M. T.; Day, R. O.; Westbrook, J. I. Consistency or efficiency? A dilemma for designers. J Am Med Inform Assoc. 2012;19:1119-20.


Wang, N.; Lipworth, W. L.; Ritchie, J. E.; Williams, K. M.; Day, R. O. Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines. Intern Med J. 2011;41(4):314-20. Epub 2010/04/21.


Stocker, S. L.; Graham, G. G.; McLachlan, A. J.; Williams, K. M.; Day, R. O. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout. J Rheumatol. 2011;38(5):904-10. Epub 2011/02/03.


Smith, M. W.; Roberts, D. M.; Ritson, S. M.; Day, R. O. Death and morbidity from supratherapeutic dosing of colchicine. Med J Aust. 2011;194(11):612-3. Epub 2011/06/08.


Roberts, D. M.; Smith, M. W.; McMullan, B. J.; Sevastos, J.; Day, R. O. Acute kidney injury due to crystalluria following acute valacyclovir overdose. Kidney Int. 2011;79(5):574. Epub 2011/02/16.


Roberts, D. M.; Smith, M. W.; Gopalakrishnan, M.; Whittaker, G.; Day, R. O. Extreme gamma-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis. Ann Emerg Med. 2011;58(1):83-5. Epub 2011/03/26.


Roberts, D. M.; Chau, A. M.; Nair, P.; Day, R. O. Enhanced elimination of phenobarbital using charcoal haemoperfusion in a patient with severe poisoning. British journal of anaesthesia. 2011;107(5):820-1. Epub 2011/10/15.


Pile, K. D.; Graham, G. G.; Mahler, S. M.; Day, R. O. Disease Modifying Antirheumatic Drugs. In: Nijkamp FP, Parnham MJ, editors. Principles of Immunopharmacology. 3rd ed. Basel, Switzerland: Birkhauser Publishing; 2011. p. 585-619.


Ng, D. Y.; Stocker, S. L.; Graham, G. G.; Williams, K. M.; Day, R. O. Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers. Eur J Clin Pharmacol. 2011;67:709-13. Epub 2010/12/25.


Milder, T. Y.; Williams, K. M.; Ritchie, J. E.; Lipworth, W. L.; Day, R. O. Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: engagement with information and perceptions of risk. Age Ageing. 2011;40(2):254-9. Epub 2010/12/29.


Milder, T. Y.; Lipworth, W. L.; Williams, K. M.; Ritchie, J. E.; Day, R. O. “It looks after me”: How older patients make decisions about analgesics for osteoarthritis. Arthritis care & research. 2011;63(9):1280-6. Epub 2011/06/15.


Lipworth, W. L.; Wodak, A. D.; Haber, P. S.; Day, R. O. Why is disulfiram not on the PBS? Med J Aust. 2011;195(7):371-2. Epub 2011/10/08.


Lipworth, W.; Kerridge, I.; Brett, J.; Day, R. How clinical and research failures lead to suboptimal prescribing: The example of chronic gout. BMJ (Clinical research ed). 2011;343:d7459. Epub 2011/12/03.


Lee, P.; Kengne, A. P.; Greenfield, J. R.; Day, R. O.; Chalmers, J.; Ho, K. K. Metabolic sequelae of beta-blocker therapy: Weighing in on the obesity epidemic? Int J Obes (Lond). 2011;35(11):1395-403. Epub 2011/02/8.


Inam, S.; Lipworth, W. L.; Kerridge, I. H.; Day, R. O. Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment. Med J Aust. 2011;195(8):446-7. Epub 2011/10/19.


Harvey, K. J.; Day, R. O.; Campbell, W. G.; Lipworth, W. Saving money on the PBS: Ranibizumab or bevacizumab for neovascular macular degeneration? Med J Aust. 2011;194(11):567-8. Epub 2011/06/08.


Greenfield, J.; Graham, G.; Day, R. The use of metformin in diabetic patients with renal impairment. Geriatric Medicine in General Practice. 2011;8:26, 8-9.


Graham, G. G.; Punt, J.; Arora, M.; Day, R. O.; Doogue, M. P.; Duong, J. K.; Furlong, T. J.; Greenfield, J. R.; Greenup, L. C.; Kirkpatrick, C. M.; Ray, J. E.; Timmins, P.; Williams, K. M. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011;50(2):81-98. Epub 2011/01/19.


Day, R. O.; Roffe, D. J.; Richardson, K. L.; Baysari, M. T.; Brennan, N. J.; Beveridge, S.; Melocco, T.; Ainge, J.; Westbrook, J. I. Implementing electronic medication management at an Australian teaching hospital. Med J Aust. 2011;195(9):498-502. Epub 2011/11/09.


Day, R.; Quinn, D.; Williams, K.; Handel, M.; Brooks, P. Connective tissue and bone disorders. 2011.


Day, R.; Lipworth, W.; Kerridge, I. Death of the ‘blockbuster’ and ‘pivotal’ clinical trial: Rethinking the drug development process. J Pharm Pract Res. 2011;41(2):94-6.


Carney, S. L.; Gazarian, M.; Denholm, J. T.; Reith, D. M.; Penhall, R. K.; Jenkins, C. R.; Wilhelm, K. A.; Komesaroff, P. A.; Osborn, M. M.; Day, R. O. What’s in a name? Brand name confusion and generic medicines. Med J Aust. 2011;195(11-12):650-1. Epub 2011/12/17.


Brett, J.; Beresford, R.; Sevastos, J.; Day, R. Neem extract poisoning as a cause of renal tubular acidosis. J Clinic Toxicol. 2011;1(3):112.


Bombardier, C.; Laine, L.; Day, R.; Hawkey, C. J.; Hochberg, M. C.; Schnitzer, T. J. Rofecoxib and clinically significant gastrointestinal events. Am J Med Sci. 2011;342(5):438-9. Epub 2011/10/28.


Baysari, M. T.; Westbrook, J. I.; Richardson, K. L.; Day, R. O. The influence of computerized decision support on prescribing during ward-rounds: Are the decision-makers targeted? J Am Med Inform Assoc. 2011;18(6):754-9. Epub 2011/06/17.


Baysari, M. T.; Westbrook, J.; Braithwaite, J.; Day, R. O. The role of computerized decision support in reducing errors in selecting medicines for prescription: narrative review. Drug Saf. 2011;34(4):289-98. Epub 2011/03/23.


Baysari, M.; Westbrook, J.; Day, R. Medication decision-making on hospital ward-rounds. In: Moen A, Andersen SK, Aarts J, Hurlen P, editors. Studies in health technology and informatics. 2011/09/07 ed. Amsterdam: IOS Press; 2011. p. 935-9.


Williams, C. M.; Latimer, J.; Maher, C. G.; McLachlan, A. J.; Cooper, C. W.; Hancock, M. J.; Day, R. O.; McAuley, J. H.; Lin, C. W. PACE–the first placebo controlled trial of paracetamol for acute low back pain: design of a randomised controlled trial. BMC Musculoskelet Disord. 2010;11:169. Epub 2010/07/24.


Westbrook, J. I.; Woods, A.; Rob, M. I.; Dunsmuir, W. T.; Day, R. O. Association of interruptions with an increased risk and severity of medication administration errors. Arch Intern Med. 2010;170(8):683-90. Epub 2010/04/28.


Stocker, S. L.; Franklin, M. E.; Anderson, J. M.; Pillans, P. I.; Williams, K. M.; McLachlan, A. J.; Day, R. O.; Taylor, P. J. Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(25):2363-8. Epub 2010/08/13.


Standfield, L.; Norris, S.; Harvey, C.; Elliot, L.; Riordan, J.; Hall, S.; Day, R.; Nash, P.; Thirunavukkarasu, K.; Robertson, J.; Palmer, T. Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: A cross-sectional, multicenter study. Clin Ther. 2010;32(7):1329-42. Epub 2010/08/04.


Palmer, H.; Graham, G.; Williams, K.; Day, R. A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeine. Pain Med. 2010;11(6):951-65. Epub 2010/07/14.


Magrabi, F.; Li, S. Y.; Day, R. O.; Coiera, E. Errors and electronic prescribing: a controlled laboratory study to examine task complexity and interruption effects. J Am Med Inform Assoc. 2010;17(5):575-83. Epub 2010/09/08.


Lu, C. Y.; Lu, V. H.; Goldberg, I.; Day, R. O. Towards integrated care: Australia’s new model of care for patients with glaucoma. Med J Aust. 2010;193(4):200-1. Epub 2010/08/18.


Indraratna, P. L.; Stocker, S. L.; Williams, K. M.; Graham, G. G.; Jones, G.; Day, R. O. A proposal for identifying the low renal uric acid clearance phenotype. Arthritis Res Ther. 2010;12(6):149. Epub 2010/12/18.


Graham, G. G.; Day, R. O.; Graudins, A.; Mohamudally, A. FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable? Inflammopharmacology. 2010;18(2):47-55. Epub 2010/03/10.


Day, R. O.; Liauw, W.; Tozer, L. M.; McElduff, P.; Beckett, R. J.; Williams, K. M. A double-blind, placebo-controlled study of the short term effects of a spring water supplemented with magnesium bicarbonate on acid/base balance, bone metabolism and cardiovascular risk factors in postmenopausal women. BMC Res Notes. 2010;3:180. Epub 2010/06/29.


Day, R. O.; Graham, G. G. Codeine —is it too risky?. Med J Aus. 2010.


Carter, S. M.; Samuel, G. N.; Kerridge, I.; Day, R.; Ankeny, R. A.; Jordens, C. F. C.; Komesaroff, P. Beyond rhetoric in debates about the ethics of marketing prescription medicines to consumers: The importance of vulnerability in people, situations, and relationships. AJOB Primary Research. 2010;1(1):11-21.


Abdul, M. I.; Jiang, X.; Williams, K. M.; Day, R. O.; Roufogalis, B. D.; Liauw, W. S.; Xu, H.; Matthias, A.; Lehmann, R. P.; McLachlan, A. J. Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects. Br J Clin Pharmacol. 2010;69(5):508-15. Epub 2010/06/25.

Published Book Chapters:


Jones GFR. Albumin in urine. Kaplan and Pesce: Methods in Clinical Chemistry. Pesce Kaplan Publishers. 2009.


Horowitz G, Jones GRD. Establishment and use of reference intervals. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier Press 2018.


Lamb EJ, Jones GRD. Kidney Function Tests. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier Press 2018.


Published Articles:


Chung JC, Jones GRD. The Effect of Acute Changes in Glomerular Filtration Rate on Common Biochemical Tests. Practical Laboratory medicine. 2022 – accepted for publication.


Radovanovic M, Norris R, Jones GRD, Day RO, Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry. J Mass Spec Adv Clin Lab 2022 (In press).


Jones GRD. Further issues with using Reference Change Values (letter) Clin Chim Acta 2022 528:13-14.


Reuter SE, Stocker Sl, Alffenaar J-WC, Baldelli S, Cattaneo Dario, Jones G, Koch BCP, Kocic D, Mathew SK, Molinaro M, Neely M, Sandaradura I, Marriott DJE. Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit 2022;44:121-32.


Badrick T, Miller WG, Paneteghini M, Delatour V, Gerghall H, Mackenzie F, Jones GRD.Interpreting EQA—Understanding Why Commutability of Materials Matters. Clinical Chemistry 2022;68:494-500.


Patela K, El-Khouryb JM, Aarsand AK, Badrick T, Jones GRD, Sikaris K, ParnasML. Current Utility and Reliability of Biological Variability. Clin Chem 2021;67:1050-5.


Ozarda Y, Ichihara K, Jones G, Streichert T, Ahmadian R on behalf of the IFCC Committee on Reference Intervals and Decision Limits (C-RIDL). Comparison of reference intervals derived by direct and indirect methods based on compatible datasets obtained in Turkey. Clin Chim Acta. 2021;520:186-95.


Tickell AM, Rohleder C, Ho N, McHugh C, Jones G, Ju Y, Song C, Hickie IB, Scott EM. Identifying pathways to early-onset metabolic dysfunction, insulin resistance and inflammation in young adult inpatients with emerging affective and major mood disorders. Early Intervention in Psychiatry. 2022.


Loh TP, Smith AF, Bell KJL, Lord SJ, Ceriotti F, Jones G, Bossuyt P, Sandberg S, Horvath AR. Setting analytical performance specifications using HbA1c as a model measurand. Clin Chim Acta 2021;523:407-14.


Roberts DM, Hughes, HK, Haber PS, Jones GRD. Variability in insulin pharmacokinetics following high-dose insulin therapy. Clinical Toxicology 2021;523:407-14.


Mukerji S, Jones GRD. Uncertainty should not be neglected in potassium correction for haemolysis. Scand J Clin Lab Invest 2021;81(6):423.


El-Khoury JM, Ovalle AA, Cervinskic MA, Levey AS, Jones GRD, Eneanya ND, Lieske JC, Jha V. Is It Time to Move On? Reexamining Race in Glomerular Filtration Rate Equations. Clin Chem 2021;67(4):585-591.


El-Khoury JM, Hoenig MP, Jones GRD, Lamb EJ, Parikh CR, Tolan NV, Wilson FP. AACC Guidance Document on Laboratory Investigation of Acute Kidney Injury. JALM 2021;6:1316-37.


Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, Clarke P, Dalbeth N, Day RO, de Zoysa JR, Douglas B, Faull R, Harris DC, Hawley CM, Jones GRD, Kanellis J, Palmer SC, Perkovic V, Rangan GK, Reidlinger D, Robison L, Walker RJ, Walters G, Johnson DW for the CKD-FIX Study Investigators. Effects of Allopurinol on the Progression of Chronic Kidney Disease. NEJM. 2020;382:2504-13.


Muir CA, Jones GRD, Greenfield JR, Weissberger A, Samaras K. Thyroid Peroxidase Antibody Positivity is Associated With Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease. Endocrine Practice 2020;26(9):1026-1030.


Miller WG, Bachmann LM, Delanghe JR, Inker LA, Jones GRD, Vassalotti JA. Optimal Biomarkers for Chronic Kidney disease. Clin Chem 2019;65:949-55.


Jones GRD. Estimates of Within-Subject Biological Variation Derived from Pathology Databases: An Approach to Allow Assessment of the Effects of Age, Sex, Time between Sample Collections, and Analyte Concentration on Reference Change Values. Clin Chem 2019;65:579-88.


Jones GRD, Haeckel R, Loh TP, Sikaris K, Streichert T, Katayev A, Barth JH, Ozarda Y, on behalf of the IFCC Committee on Reference Intervals and Decision Limits. Indirect methods for reference interval determination – review and recommendations. Clin Chem Lab Med 2019;57:20–9.


Koerbin G, Sikaris K, Jones GRD, Flatman R, Tate JR on behalf of the AACB Harmonization Committee for Common Reference Intervals. An update report on the harmonization of adult reference intervals in Australasia. CCLM 2019;57:38-41.


Jones GRD, Bryant S, Fullinfaw R, Ilett K, Miners JO, Morris RG, Doogue MP. Mass or molar? Recommendations for reporting concentrations of therapeutic drugs. Med J Aust 2013;198:368-369.


Adams O, Cooper G, Fraser C, Hubmann M, Jones G, Plebani M, Sonntag O, Vaubourdolle M. Collective opinion paper on findings of the 2011 convocation of experts on laboratory quality. Clin Chem Lab Med. 2012;50:1547-1558.


Maple-Brown LJ, Hughes JT, Lawton PD, Jones GRD, Ellis AG, Drabsch K, Cass A, Hoy WE, MacIsaac RJ, O’Dea K, Jerums G. Am J Kid. Accurate Assessment of Kidney Function in Indigenous Australians: the eGFR Study. Dis. 2012; 60:679-682.


Ong M-S, Magrabi F, Jones G, Coiera E. Last Orders: Follow-up of Tests Ordered on the Day of Hospital Discharge. Arch Int Med. 2012;172(17):1347-1349


d-Emden MC, Shaw JE, Colman PG, Coliaguri S, Twigg SM, Jones GRD, Goodall I, Schneider HG, Cheung NW. The Role of HbA1c in the diagnosis of diabetes mellitus in Australia. MJA 2012;197:220-222.


Johnson DW, Jones GRD, Mathew TH, Ludlow MJ, Doogue MP, Jose MD, Langham RG, Lawton PD, McTaggart SJ, Peake MJ, Polkinghorne K, Usherwood T, MJA Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. 2012;197:224-225.


Johnson SW, Jones GRD, Mathew TH, Ludlow MJ, Chadban SJ, Usherwood T, Polkinghorne K, Colagiuri S, Jerums G, MacIsaac R, Martin H, MJA Australasian Proteinuria Consensus Working Group. Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement. 2012;197:226-228.


Jones GRD, Panteghini M. Pre-analytical factors affecting troponin measurement. Clin Biochem Rev Monograph 2012; 63-68.


Jones GRD, Finckh A, Wilson S. Introducing high sensitivity troponin into routine use – A worked example. Clin Biochem Rev Monograph 2012;97-102.


Jones GRD, Sikaris K, Gill J. Allowable Limits of Performance’ for External Quality Assurance Programs – an Approach to Application of the Stockholm Criteria by the RCPA Quality Assurance Programs. Clin Biochem Rev 2012;33:133-9


von Eckardstein A, Roth HJ, Jones G, Preston S, Szekeres T, Imdahl R, Conti M, Blanckaert N, Jose D, Thiery J, Feldmann L, von Ahsen N, Locatelli M, Kremastinou J, Kunst A, Hubbuch A, McGovern M. Cobas 8000 Modular Analyzer Series Evaluated under Routine-like Conditions at 14 Sites in Australia, Europe, and the United States. Journal of Laboratory Automation, 2012.


Jones GRD, Barker G, Goodall I, Schneider HG, Shephard MDR, Twigg SM. Change of HbA1c reporting of the new SI units. MJA 2011;195:45-6.


Jones GRD Laboratory reporting of urine protein and albumin. Clin Biochem Revs 2011;32:107-11.


Jones GRD. Estimating renal function for drug dosing decisions. Clin Biochem Revs 2011;32:85-92.


Miller WG, Jones GRD, Horowitz GL, Weycamp C. Proficiency Testing/External Quality Assessment: Current Challenges and Future Directions. Clin Chem 2011;57:1670-80.

Published Articles:


Moore, J, Nivison-Smith, I, Goh, K, Ma, D, Bradstock, K, Szer, J, Durrant, S, Schwarer, A, Bardy, P, Herrman, R, Dodds, A. Equivalent Survival for Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation, 2007, 13, 601-607


JC Kovacic, P Macdonald, MP Feneley, DW Muller, J Freund, A Dodds, S Milliken, H Tao, S Itescu, J Moore, D Ma, and RM Graham. Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial. Am Heart J, 2008; 156(5): 954-63


Edward A. Copelan, Pamela Ann Crilley, Jeffrey Szer, Anthony J. Dodds, Dustin Stevenson, Gary Phillips, Patrick Elder, Ian Nivison-Smith, Belinda R. Avalos, Sam Penza, David Topolsky, Ronald Sobecks, Matt Kalaycio, Brian J. Bolwell. Late Mortality and Relapse following BuCy2 and HLA-Identical Sibling Marrow Transplantation for Chronic Myelogenous Leukemia. Biol Blood Marrow Transplant. 2009, 15, 851-855


Dodds A. Emergency Department Haematology in: Emergency Medicine. The Principles of Practice, 5th edition. Churchill Livingstone. Ed. Gordian Fulde. 2009; Ch.43: 687-696


Nivison-Smith I, Simpson JM, Dodds AJ, Ma DDF, Szer J, Bradstock KF. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates. Biol Blood Marrow Transplant 2009; 15: 1323 – 1330


Paul J Shaughnessy,, Brian J Bolwell, Koen van Besien, Martin Mistrik, Andrew Grigg, Anthony Dodds,, H Miles Prince, Simon Durrant,, Osman Ilhan, Dennis Parenti,, Jon Rogers, Jose Gallo, Francine Foss, Jane Apperley, Mei-Jie Zhang, Mary M Horowitz, MD, , Suni Abhyankar. Extracorporeal Photopheresis for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation, Bone Marrow Transplant, Jun 2010; 45(6): 1068-76


Shubham Pant, Mehdi Hamadani, Anthony J Dodds, Jeffrey Szer, Pamela A Crilley, Dustin Stevenson, Gary Phillips, Patrick Elder, Ian Nivison-Smith, Belinda R Avalos, Sam Penza, David Topolsky, Ronald Sobecks, Matt Kalaycio, Brian J Bolwell, and Edward A Copelan. Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia. Br J Haematol, Feb 2010; 148(4): 623-6


Nivison-Smith, AJ Dodds, H Dunckley, DD Ma, JJ Moore, JM Simpson, J Szer, and KF Bradstock. Increased activity and improved outcome in unrelated donor hematopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005 Intern Med J, 2011;41:27-34


Nivison-Smith, A Dodds, R Doocey et al. Allogeneic hematopoietic cell transplantation for multiple myeloma using reduced intensity conditioning therapy, 18-2006, factors associated with improved survival outcome. Leukemia & Lymphoma, September 2011; 52(9): 1727–1735


Nivison-Smith I, Dodds AJ, Butler J, Bradstock KF, Ma DDF, Simpson JM, Szer J. Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk. Biol Blood Marrow Transplant 2012; 18(2):302-308

To view our Test Information Sheets please click here.